Surmodics Reports Real-World Pounce Thrombectomy System Findings
Surmodics (Nasdaq:SRDX) announced results from a sex-specific analysis of real-world patients in a study of its Pounce thrombectomy system.
The analysis evaluated 160 acute, subacute and chronic thrombotic limb ischemia patients from the PROWL registry.
Peter Monteleone presented findings at the 2025 Transcatheter Cardiovascular Therapeutics conference in San Francisco.
PROWL evaluates the Pounce system for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
The registry collects real-world efficacy and safety outcomes for endovascular interventions using the fully mechanical, non-aspiration-based system.
Surmodics describes Pounce systems as
“grab-and-go” solutions— deployable and simple to use.
Each system features a delivery catheter, a basket wire and a funnel catheter.
Author summary: Surmodics reports Pounce system findings.
More News
- Sanderson's late game-tying goal propels Senators past Flames in shootout for comeback win | Ottawa Senators
- Historic Santa Barbara Mission Faces New Housing Showdown | News Channel 3-12
- 12 A-List Actors Who Got Their Start in Horror Movies
- Creators Are Ditching Google For Substack – Here’s Why…
- Zegras has 3 points, Flyers defeat Predators for 3rd straight win | NHL.com
- Wood Scores First NHL Goal as Preds Fall to Flyers | Nashville Predators